BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
T cell receptor signaling pathway
,
Inflammatory disorder
,
Breast
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SCPs
Summary
General Info
Curated Studies
Most Correlated Studies
Schwann cells and Schwann cell progenitors from plexiform neurofibromas
Subpopulations of MDA-MB-231 of various propensities for lung metastasis and primary breast cancers
SW-480 colorectal cancer cell gene expression in high and low metastatic variants
Explore Curated Studies Results
Literature
Most Relevant Literature
Single-cell protein: overcoming technological and biological challenges towards improved industriali…
Production of single cell protein from brewer's spent grain through enzymatic saccharification and f…
Replacement of fishmeal with a microbial single-cell protein induced enteropathy and poor growth out…
Urocortin 3 contributes to paracrine inhibition of islet alpha cells in mice.
Economical production of Pichia pastoris single cell protein from methanol at industrial pilot scale…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SCP® Observational Study of the Knee
SCP Hip Outcomes Study
Safety and Performance of the EndoFast Reliant SCP in Vaginal Wall Reinforcement
SCP vs HUSLS for Pelvic Organ Prolapse Repair
NIRS Measurement After SCP Block
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ